MX350707B - Composiciones antigenas y procedimientos. - Google Patents

Composiciones antigenas y procedimientos.

Info

Publication number
MX350707B
MX350707B MX2014011712A MX2014011712A MX350707B MX 350707 B MX350707 B MX 350707B MX 2014011712 A MX2014011712 A MX 2014011712A MX 2014011712 A MX2014011712 A MX 2014011712A MX 350707 B MX350707 B MX 350707B
Authority
MX
Mexico
Prior art keywords
methods
multilayer films
antigenic compositions
host
polypeptide epitopes
Prior art date
Application number
MX2014011712A
Other languages
English (en)
Other versions
MX2014011712A (es
Inventor
Thomas J Powell
James Gorham Boyd
Original Assignee
Artificial Cell Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artificial Cell Tech Inc filed Critical Artificial Cell Tech Inc
Publication of MX2014011712A publication Critical patent/MX2014011712A/es
Publication of MX350707B publication Critical patent/MX350707B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a películas multicapa compuestas por epítopos polipeptídicos y un ligando para el receptor tipo toll. Las películas multicapa son capaces de producir una respuesta inmunitaria en un huésped tras su administración al huésped. Las películas multicapa pueden incluir al menos un péptido diseñado que incluye uno o más epítopos peptídicos de un virus, bacteria, hongo o parásito.
MX2014011712A 2012-03-30 2013-03-20 Composiciones antigenas y procedimientos. MX350707B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261618021P 2012-03-30 2012-03-30
US201261647105P 2012-05-15 2012-05-15
PCT/US2013/033071 WO2013148427A1 (en) 2012-03-30 2013-03-20 Antigenic compositions and methods

Publications (2)

Publication Number Publication Date
MX2014011712A MX2014011712A (es) 2015-02-04
MX350707B true MX350707B (es) 2017-09-14

Family

ID=48040469

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011712A MX350707B (es) 2012-03-30 2013-03-20 Composiciones antigenas y procedimientos.

Country Status (13)

Country Link
US (3) US8883717B2 (es)
EP (1) EP2830652B1 (es)
JP (1) JP6228967B2 (es)
CN (2) CN106110320A (es)
AU (1) AU2013240106B2 (es)
BR (1) BR112014024375B1 (es)
CA (1) CA2868455C (es)
DK (1) DK2830652T3 (es)
ES (1) ES2612357T3 (es)
HK (1) HK1206970A1 (es)
IL (1) IL234695B (es)
MX (1) MX350707B (es)
WO (1) WO2013148427A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5890407B2 (ja) * 2010-07-07 2016-03-22 アーティフィシャル セル テクノロジーズ インコーポレイテッド 呼吸器合胞体ウイルス抗原組成物および方法
US9433671B2 (en) 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
EP3148713A4 (en) * 2014-05-27 2018-01-17 Artificial Cell Technologies, Inc. Automated layer by layer construction of multilayer coated cores by tff
US20160023404A1 (en) * 2014-07-25 2016-01-28 Stephen Raymond Anderson Three-dimensional manufacturing, fabricating, forming, and/or repairing apparatus and method
IL257895B2 (en) 2015-09-16 2024-03-01 Artificial Cell Tech Inc Preparations and methods against malaria
CN112390660B (zh) * 2020-10-29 2022-08-09 成都聚力混凝土有限公司 一种护坡绿化专用的植被混凝土及其制备方法
US20230414526A1 (en) * 2022-03-29 2023-12-28 Artificial Cell Technologies, Inc. Respiratory syncytial virus antigenic compositions and methods
US20240122845A1 (en) * 2022-09-20 2024-04-18 Artificial Cell Technologies, Inc. Administration regimens for microneedle patch devices for delivery of immunogenic compositions

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3734263B2 (ja) 1993-05-25 2006-01-11 ワイス・ホールディングズ・コーポレイション 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント
BR9407397A (pt) * 1993-07-12 1996-11-05 Virus Res Inst Vacinas microencapsuladas em hidrogel
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
ES2535451T3 (es) 2002-08-12 2015-05-11 The Council Of The Queensland Institute Of Medical Research Nuevos lipopéptidos inmunógenos que comprenden epítopos de linfocitos T auxiliares y de linfocitos T citotóxicos (CTL)
WO2004108072A2 (en) 2003-04-10 2004-12-16 3M Innovative Properties Company Delivery of immune response modifier compounds using metal-containing particulate support materials
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
EP1850832B1 (en) * 2005-02-07 2014-12-31 Lipotek PTY Ltd Adjuvanting material
DE102005044400A1 (de) 2005-09-16 2007-03-22 Capsulution Nanoscience Ag Verfahren zur Verkapselung und kontrollierten Freisetzung von schwer wasserlöslichen (hydrophoben) flüssigen und festen Wirkstoffen
WO2007050702A2 (en) * 2005-10-25 2007-05-03 Donald Templeton Haynie Immunogenic compositions and methods of use
US8951528B2 (en) 2006-02-22 2015-02-10 3M Innovative Properties Company Immune response modifier conjugates
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
US7723294B2 (en) 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP2002847A1 (en) 2007-06-12 2008-12-17 Capsulution Nanoscience AG Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
WO2009082440A2 (en) 2007-12-18 2009-07-02 Vaxinnate Corporation Compositions of toll-like receptor agonists and malaria antigens and methods of use
US7846824B2 (en) 2008-03-18 2010-12-07 Applied Materials, Inc. Methods for forming a titanium nitride layer
WO2010115229A1 (en) * 2009-04-09 2010-10-14 The University Of Melbourne Immunogenic composition and uses thereof
JP5890407B2 (ja) 2010-07-07 2016-03-22 アーティフィシャル セル テクノロジーズ インコーポレイテッド 呼吸器合胞体ウイルス抗原組成物および方法
EP2616098B1 (en) * 2010-09-14 2016-04-20 Council of Scientific & Industrial Research A synthetic immunogen useful for generating long lasting immunity and protection against pathogens
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US9433671B2 (en) 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2015104352A1 (en) 2014-01-09 2015-07-16 Alpha-O Peptides Ag Flagellin-containing protein nanoparticles as a vaccine platform
IL257895B2 (en) 2015-09-16 2024-03-01 Artificial Cell Tech Inc Preparations and methods against malaria

Also Published As

Publication number Publication date
DK2830652T3 (en) 2017-01-30
JP2015516954A (ja) 2015-06-18
EP2830652A1 (en) 2015-02-04
US20130259946A1 (en) 2013-10-03
CN104220089B (zh) 2016-08-24
US20150030682A1 (en) 2015-01-29
EP2830652B1 (en) 2016-11-02
US8883717B2 (en) 2014-11-11
US20160166669A1 (en) 2016-06-16
ES2612357T3 (es) 2017-05-16
JP6228967B2 (ja) 2017-11-08
US9302001B2 (en) 2016-04-05
BR112014024375B1 (pt) 2022-08-16
CN104220089A (zh) 2014-12-17
WO2013148427A1 (en) 2013-10-03
BR112014024375A2 (es) 2017-06-20
IL234695A0 (en) 2014-11-30
IL234695B (en) 2019-06-30
CA2868455A1 (en) 2013-10-03
AU2013240106A1 (en) 2014-10-02
HK1206970A1 (en) 2016-01-22
CN106110320A (zh) 2016-11-16
CA2868455C (en) 2021-01-12
MX2014011712A (es) 2015-02-04
AU2013240106B2 (en) 2016-11-10
US9925252B2 (en) 2018-03-27

Similar Documents

Publication Publication Date Title
MX350707B (es) Composiciones antigenas y procedimientos.
MX2015008847A (es) Composiciones inmunogenicas de virus de influenza y usos de las mismas.
MX2017001638A (es) Molecula portadora para antigenos.
MX340796B (es) Composiciones y procedimientos antigenicos del virus respiratorio sincitial.
EP3110401A4 (en) Lipid nanoparticle vaccine adjuvants and antigen delivery systems
MX2020004906A (es) Nanoportadores sinteticos tolerogenicos.
MX357202B (es) Composicion de particula tipo virus.
IN2014KN03063A (es)
EP4056198A3 (en) Outer membrane vesicles
MX342716B (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
EP3112378A4 (en) Wt1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
WO2013054199A3 (en) Cmv antigens and uses thereof
PH12015501101B1 (en) Method for eliciting an immune response to an immunogen
NZ729519A (en) Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin
WO2014136064A3 (en) Immunogenic fusion polypeptides
MX2016014414A (es) Vacuna de peptido que comprende un peptido ras mutante y un agente quimioterapeutico.
MX350709B (es) Composiciones y procedimientos antipaludismo.
WO2015179270A3 (en) Combinatorial platform for the display of surface adjuvants and antigens
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
EP2762153A3 (en) Vaccine composition for mucosal administration
IN2014CH00391A (es)
MX2021013109A (es) Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue.
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
IN2014CH00395A (es)
EP3416681A4 (en) NOVEL ANTIGEN FOR USE IN ANTI-MALARIA VACCINE

Legal Events

Date Code Title Description
FG Grant or registration